253 related articles for article (PubMed ID: 29241220)
1. High-Risk Human Papillomavirus in Oral Cancer: Clinical Implications.
Yete S; D'Souza W; Saranath D
Oncology; 2018; 94(3):133-141. PubMed ID: 29241220
[TBL] [Abstract][Full Text] [Related]
2. The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.
Kansy K; Thiele O; Freier K
Oral Maxillofac Surg; 2014 Jun; 18(2):165-72. PubMed ID: 23242943
[TBL] [Abstract][Full Text] [Related]
3. Cancer. HPV casts a wider shadow.
Zelkowitz R
Science; 2009 Jan; 323(5914):580-1. PubMed ID: 19179508
[No Abstract] [Full Text] [Related]
4. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India.
Patel KR; Vajaria BN; Begum R; Desai A; Patel JB; Shah FD; Shukla SN; Patel PS
J Oral Pathol Med; 2014 Apr; 43(4):293-7. PubMed ID: 24372728
[TBL] [Abstract][Full Text] [Related]
5. Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 108():2-32. PubMed ID: 19939209
[TBL] [Abstract][Full Text] [Related]
6. [Papillomavirus and head and neck cancer].
Lescaille G; Descroix V; Azérad J
Rev Stomatol Chir Maxillofac; 2011 Jun; 112(3):160-3. PubMed ID: 21596407
[TBL] [Abstract][Full Text] [Related]
7. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.
Lingen MW; Xiao W; Schmitt A; Jiang B; Pickard R; Kreinbrink P; Perez-Ordonez B; Jordan RC; Gillison ML
Oral Oncol; 2013 Jan; 49(1):1-8. PubMed ID: 22841678
[TBL] [Abstract][Full Text] [Related]
8. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers.
Smith EM; Ritchie JM; Summersgill KF; Klussmann JP; Lee JH; Wang D; Haugen TH; Turek LP
Int J Cancer; 2004 Feb; 108(5):766-72. PubMed ID: 14696105
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive meta-analytical summary on human papillomavirus association with head and neck cancer.
Bychkov VA; Nikitina EG; Ibragimova MK; Kaigorodova EV; Choinzonov EL; Litviakov NV
Exp Oncol; 2016 Jun; 38(2):68-72. PubMed ID: 27356572
[TBL] [Abstract][Full Text] [Related]
10. Overview of high-risk HPV's 16 and 18 infected cervical cancer: pathogenesis to prevention.
Ramakrishnan S; Partricia S; Mathan G
Biomed Pharmacother; 2015 Mar; 70():103-10. PubMed ID: 25776487
[TBL] [Abstract][Full Text] [Related]
11. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic.
Tachezy R; Klozar J; Saláková M; Smith E; Turek L; Betka J; Kodet R; Hamsíková E
Oral Dis; 2005 May; 11(3):181-5. PubMed ID: 15888110
[TBL] [Abstract][Full Text] [Related]
12. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus frequency in oral and oropharyngeal cancer in Greece.
Romanitan M; Näsman A; Ramqvist T; Dahlstrand H; Polykretis L; Vogiatzis P; Vamvakas P; Tasopoulos G; Valavanis C; Arapantoni-Dadioti P; Banis K; Dalianis T
Anticancer Res; 2008; 28(4B):2077-80. PubMed ID: 18751378
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.
Gillison ML; Alemany L; Snijders PJ; Chaturvedi A; Steinberg BM; Schwartz S; Castellsagué X
Vaccine; 2012 Nov; 30 Suppl 5():F34-54. PubMed ID: 23199965
[TBL] [Abstract][Full Text] [Related]
15. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
Brotherton JM
Vaccine; 2008 Jan; 26(2):250-6. PubMed ID: 18068276
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus types in cervical and oral cancers in central India.
Gheit T; Vaccarella S; Schmitt M; Pawlita M; Franceschi S; Sankaranarayanan R; Sylla BS; Tommasino M; Gangane N
Vaccine; 2009 Jan; 27(5):636-9. PubMed ID: 19056450
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus in head and neck cancers: biology, prognosis, hope of treatment, and vaccines.
Psyrri A; Boutati E; Karageorgopoulou S
Anticancer Drugs; 2011 Aug; 22(7):586-90. PubMed ID: 21403517
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: a retrospective analysis of 88 patients and literature overview.
Krüger M; Pabst AM; Walter C; Sagheb K; Günther C; Blatt S; Weise K; Al-Nawas B; Ziebart T
J Craniomaxillofac Surg; 2014 Oct; 42(7):1506-14. PubMed ID: 24947612
[TBL] [Abstract][Full Text] [Related]
19. HPV16 infection in oral cavity and oropharyngeal cancer patients.
Dang J; Feng Q
J Oral Sci; 2016; 58(2):265-9. PubMed ID: 27349549
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
